Wai-Shing Leung
-
Research
![Photo of [Science] Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans](https://fightcovid19.hku.hk/content/uploads/2020/08/F1.large_-390x220.jpg)
[Science] Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Science, 11 August 2020 Prabhu S. Arunachalam, Florian Wimmers, Chris Ka Pun Mok, Ranawaka A. P. M. Perera, Madeleine Scott,…
Read More » -
Research
![Photo of [Emerging Microbes & Infections] High neutralizing antibody titer in intensive care unit patients with COVID-19](https://fightcovid19.hku.hk/content/uploads/2020/07/temi_a_1791738_f0003_oc-390x220.jpeg)
[Emerging Microbes & Infections] High neutralizing antibody titer in intensive care unit patients with COVID-19
Emerging Microbes & Infections, 3 July 2020 Li Liu , Kelvin Kai-Wang To , Kwok-Hung Chan , Yik-Chun Wong ,…
Read More » -
Research
![Photo of [Cell Reports] Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections](https://fightcovid19.hku.hk/content/uploads/2020/05/fx1_lrg-1-390x220.jpg)
[Cell Reports] Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
Cell Reports, 17 May 2020 Huibin Lv, Nicholas C. Wu, Owen Tak-Yin Tsang, Meng Yuan, Ranawaka A.P. M. Perera, Wai…
Read More » -
Research
![Photo of [The Lancet] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial](https://fightcovid19.hku.hk/content/uploads/2020/02/cover-yuen-kwok-yung-1024x538-1-390x220.png)
[The Lancet] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
The Lancet, May 8 2020 Ivan Fan-Ngai Hung,Kwok-Cheung Lung,Eugene Yuk-Keung Tso,Raymond Liu,Tom Wai-Hin Chung,Man-Yee Chu,Yuk-Yung Ng,Jenny Lo,Jacky Chan,Anthony Raymond Tam,Hoi-Ping…
Read More »